Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
RSV Infection Burden High in Immunocompromised Adults
July 2026
RSV infection poses a substantial severe disease burden for immunocompromised adults in high-income countries.
Read more
4 Jul 2026
RSV Infection Burden High in Immunocompromised Adults
RSV infection poses a substantial severe disease burden for immunocompromised adults in high-income countries.
30 Jun 2026
Cystic Fibrosis Care Remains Below Pre-pandemic Levels
Cystic fibrosis care utilization remained below 2019 levels in adults and children through 2023.
25 Jun 2026
Bronchiectasis Outcomes Worsen with Diabetes
Bronchiectasis and diabetes were linked to greater disease severity, microbial shifts, and increased five-year mortality in international registries.
24 Jun 2026
Vaping and Cancer Link Can No Longer Be Ignored
E-cigarettes may be carcinogenic, with evidence linking vaping to DNA damage, inflammation, and cancer-related biomarkers
20 Jun 2026
CFTR Modulators Linked to Lower Anxiety in Cystic Fibrosis
CFTR modulators may offer early mental health benefits for children with cystic fibrosis and their parents.
18 Jun 2026
Bronchiectasis Care Enters Targeted Treatment Era
DPP-1 inhibitors are reshaping bronchiectasis care by targeting neutrophilic airway inflammation and reducing pulmonary exacerbations.
16 Jun 2026
Remote Monitoring Fails to Reduce Readmissions After Sepsis
Remote monitoring did not reduce readmissions after sepsis or lower respiratory tract infection, trial data show.
9 Jun 2026
Cell Reprogramming Drives Lung Cancer Resistance
Lung adenocarcinoma plasticity may drive progression and treatment resistance through TP53-linked developmental reprogramming, new data suggest.
Loading posts...
1
2
3
…
37
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View